From data to regulatory submission
Clinical trial documentation is one of the most labor-intensive aspects of drug development. Patient narratives, Clinical Study Reports (CSRs), and Tables, Listings, and Figures (TLFs) often involve massive volumes of structured data and painstaking manual effort from medical writing teams.
To tackle this challenge, this top biopharmaceutical company has adopted Narrativa’s AI-powered Medical Writing Platform, a proprietary solution that transforms clinical data directly into regulatory-ready documents.
This top biopharmaceutical company leverages Narrativa’s AI-powered platform to automate the creation of clinical documents—turning weeks of manual work into just hours. Powered by AI, their teams now generate regulator-ready drafts faster than ever, streamlining approvals and delivering treatments to patients sooner.
How the platform works
Narrativa’s platform combines AI agents with a proprietary Knowledge Graph, ensuring accurate, traceable, and regulator-ready content generation. The AI is configured to align with each sponsor’s documentation standards, enabling:
- Patient Narratives
- CSRs
- TLFs
- Redaction & Anonymization
Medical writers receive high-quality first drafts, freeing them to focus on quality control, final review, and strategic input.
The impact: simpler, smarter, faster clinical trials
With this implementation, this company is set to unlock a range of powerful benefits:
- Faster approvals: Initial drafts delivered in hours instead of weeks accelerate the clinical trial timeline.
- Lower risk: Automated data interpretation reduces human error and improves regulatory compliance.
- Cost efficiency: Fewer manual hours translate to leaner operations and reduced overhead.
- Operational simplicity: Automation minimizes the number of stakeholders involved—streamlining collaboration and version control.
A shared vision for global health
Backed by over 50 years of pharmaceutical leadership and a presence in more than 50 countries, this top company’s mission is to improve access to quality medicines. Partnering with Narrativa aligns with their focus on R&D innovation and commitment to delivering treatments to patients faster, safer, and at a lower cost.
This collaboration is not just about speeding up paperwork—it’s about enabling life-saving solutions to reach those who need them most.
About Narrativa
Narrativa® Agentic AI solutions unlock a faster, smarter future for life sciences organizations, helping them to efficiently produce complex, high-volume documentation for regulatory and commercialization workflows. By automating content creation, Narrativa® delivers greater speed, accuracy, and consistency—while ensuring full compliance in highly regulated environments.
The Narrativa® Navigator platform provides secure and specialized Agentic AI-powered automation features. It includes complementary user-friendly tools such as Coauthor for CSR and Protocol generation, Pathway, Scout, and Developer, which operate cohesively to transform clinical data into submission-ready documents for regulatory and commercialization. From database to delivery, pharmaceutical sponsors, biotech firms, and contract research organizations (CROs) rely on Narrativa® to streamline workflows, decrease costs, and reduce time-to-market across the clinical lifecycle and, more broadly, throughout their entire businesses.
Explore www.narrativa.com and follow on LinkedIn, Facebook, Instagram, and X.